A comparative post hoc analysis of finerenone and spironolactone in resistant hypertension in moderate-to-advanced chronic kidney disease.
- DOI
- 10.1093/ckj/sfac234
- Published
- 2023 Feb
- Container
- Clinical kidney journal
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1093/ckj/sfac234,
title = {A comparative post hoc analysis of finerenone and spironolactone in resistant hypertension in moderate-to-advanced chronic kidney disease.},
author = {Agarwal R and Pitt B and Palmer BF and Kovesdy CP and Burgess E and Filippatos G and Małyszko J and Ruilope LM and Rossignol P and Rossing P and Pecoits-Filho R and Anker SD and Joseph A and Lawatscheck R and Wilson D and Gebel M and Bakris GL},
year = {2023},
journal = {Clinical kidney journal},
doi = {10.1093/ckj/sfac234},
url = {https://doi.org/10.1093/ckj/sfac234}
}RIS
TY - JOUR TI - A comparative post hoc analysis of finerenone and spironolactone in resistant hypertension in moderate-to-advanced chronic kidney disease. AU - Agarwal R AU - Pitt B AU - Palmer BF AU - Kovesdy CP AU - Burgess E AU - Filippatos G AU - Małyszko J AU - Ruilope LM AU - Rossignol P AU - Rossing P AU - Pecoits-Filho R AU - Anker SD AU - Joseph A AU - Lawatscheck R AU - Wilson D AU - Gebel M AU - Bakris GL PY - 2023 JO - Clinical kidney journal DO - 10.1093/ckj/sfac234 UR - https://doi.org/10.1093/ckj/sfac234 ER -
APA
R, A., B, P., BF, P., CP, K., E, B., G, F., J, M., LM, R., P, R., P, R., R, P., SD, A., A, J., R, L., D, W., M, G., & GL, B. (2023). A comparative post hoc analysis of finerenone and spironolactone in resistant hypertension in moderate-to-advanced chronic kidney disease.. Clinical kidney journal. https://doi.org/10.1093/ckj/sfac234
Source records
- pubmed · retrieved 2026-09-26T13:10:27.444Z
- europe-pmc · retrieved 2026-09-26T13:10:27.431Z
- hal · retrieved 2026-09-26T13:10:27.471Z